Udaya Rangaswamy, Ph.D.Senior Scientist at Rondo therapeuticsSpeaker
Profile
Udaya Rangaswamy leads the translational biology team at Rondo therapeutics, a clinical stage company focused on co-stimulatory T cell engagers for treating solid tumors. She has supported and led T cell engager programs in heme-onc and solid tumors at various stages from discovery through IND enabling studies at Rondo and her prior roles at Amgen and Teneobio.
Agenda Sessions
Combination of Signal 1 and Signal 2 T Cell Engagers for Treatment of Ovarian Cancer
, 2:30pmView SessionCo-Chairs’ Remarks
, 8:10amView Session
